Identification of two novel mutations besides JAK2V617F in a patient with polycythemia vera

被引：0
|
作者：
Xie, X. [1 ]
Koffke-Marchant, K. [1 ]
Lichtin, A. [1 ]
Palinchik, K. [1 ]
Jakubowski, M. [1 ]
Murugesan, G. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2007年 / 9卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：670 / 670
页数：1
相关论文
共 50 条
  • [21] Cerebral venous sinus thrombosis in polycythemia vera patients with JAK2V617F mutation
    Shen, Hui-Xin
    Huang, Xiao-Qin
    Fan, Chun-Qiu
    Cao, Yan-Xiang
    Zhao, Hong
    Duan, Jian-Gang
    CHINESE MEDICAL JOURNAL, 2021, 134 (10) : 1251 - 1253
  • [22] JAK2V617F mutation is common in old patients with polycythemia vera and essential thrombocythemia
    Maria Luigia Randi
    Elisabetta Ruzzon
    Fabiana Tezza
    Margherita Scapin
    Elena Duner
    Raffaella Scandellari
    Fabrizio Fabris
    Aging Clinical and Experimental Research, 2011, 23 : 17 - 21
  • [23] Influence of JAK2V617F Allele Burden on Hematological Response in the Treatment of Polycythemia Vera
    Shikhbabaeva, Dzhariyat
    Shuvaev, Vasily
    Golovchenko, Regina
    Udaleva, Vera
    Fominykh, Mikhail
    Zotova, Irina I.
    Polushkina, Lyubov
    Martynkevich, Irina
    Abdulkadyrov, Kudrat
    BLOOD, 2016, 128 (22)
  • [24] Usefulness of JAK2V617F mutation in distinguishing idiopathic erythrocytosis from polycythemia vera
    Rossi, davide
    Cortini, Francesca
    Deambrogi, Clara
    Barbieri, Caterina
    Cerri, Michaela
    Franceschetti, Silvia
    Conconi, Annarita
    Capello, Daniela
    Gaidano, Gianluca
    LEUKEMIA RESEARCH, 2007, 31 (01) : 97 - 101
  • [25] Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth
    Li, Zhe
    Xu, Mingjiang
    Xing, Shu
    Ho, Wanting Tina
    Ishii, Takefumi
    Li, Qingshan
    Fu, Xueqi
    Zhao, Zhizhuang Joe
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (06) : 3428 - 3432
  • [26] JAK2V617F mutation is common in old patients with polycythemia vera and essential thrombocythemia
    Randi, Maria Luigia
    Ruzzon, Elisabetta
    Tezza, Fabiana
    Scapin, Margherita
    Duner, Elena
    Scandellari, Raffaella
    Fabris, Fabrizio
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2011, 23 (01) : 17 - 21
  • [27] The Calreticulin control of human stress erythropoiesis is impaired by JAK2V617F in polycythemia vera
    Falchi, Mario
    Varricchio, Lilian
    Martelli, Fabrizio
    Marra, Manuela
    Picconi, Orietta
    Tafuri, Agostino
    Girelli, Gabriella
    Uversky, Vladimir N.
    Migliaccio, Anna Rita
    EXPERIMENTAL HEMATOLOGY, 2017, 50 : 53 - 76
  • [28] Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia vera
    Tefferi, A.
    Strand, J. J.
    Lasho, T. L.
    Knudson, R. A.
    Finke, C. M.
    Gangat, N.
    Pardanani, A.
    Hanson, C. A.
    Ketterling, R. P.
    LEUKEMIA, 2007, 21 (09) : 2074 - 2075
  • [29] JAK2V617F mutational frequency in polycythemia vera:: 100%, > 90%, less?
    Verstovsek, S.
    Silver, R. T.
    Cross, N. C. P.
    Tefferi, A.
    LEUKEMIA, 2006, 20 (11) : 2067 - 2067
  • [30] Detection of JAK2V617F used for diagnosis of polycythemia vera and correlation with other biomarkers
    Daniels, L.
    Vermeulen, K.
    Van De Velde, A. L.
    Vrelust, I.
    Gadisseur, A. P.
    Schroyens, W.
    Berneman, Z. N.
    ACTA CLINICA BELGICA, 2007, 62 (04): : 262 - 262
12345